Literature DB >> 30784279

Long non-coding RNA HOXB-AS1 promotes proliferation, migration and invasion of glioblastoma cells via HOXB-AS1/miR-885-3p/HOXB2 axis.

X Chen1, L Q Li2, X Qiu3, H Wu1.   

Abstract

Long non-coding RNAs (lncRNAs) have been proved to play important roles in carcinogenesis and development of numerous cancers, but their biological functions in glioblastoma remain largely unknown. In this study, we found HOXB-AS1 was highly expressed in human glioblastoma tissues and cell lines, and was associated with survival time of patients. Our results showed HOXB-AS1 knockdown inhibited proliferation via inducing S phase cell cycle arrest, and suppressed migration ability of cells. In terms of mechanism, HOXB-AS1 were mainly located in cytoplasm and functioned as ceRNA via sponging of miR-885-3p. We proved inhibition of miR-885-3p antagonized the effects of HOXB-AS1 konckdown and promoted the proliferation and migration of glioblastoma. Finally, we found the sponging of miR-885-3p by HOXB-AS1 could further affecting the expression of HOXB2. Taken together, we demonstrated that HOXB-AS1/miR-885-3p/HOXB2 axis could regulate the proliferation and migration of glioblastoma, which could serve as a potential biomarker for glioblastoma patients.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30784279     DOI: 10.4149/neo_2018_180606N377

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  14 in total

1.  Comprehensive bioinformatics analyses identified Homeobox B9 as a potential prognostic biomarker and therapeutic target for gastric cancer.

Authors:  Xiaofei Li; Shujia Chen; Yinghui Zhu; Jiayue Fei; Liaoyuan Song; Guoyan Sun; Wei Niu; Lianyi Guo; Jiwei Wang
Journal:  J Gastrointest Oncol       Date:  2021-10

2.  Aberrant Protein Glycosylation in Brain Cancers, with Emphasis on Glioblastoma.

Authors:  Livia Rosa-Fernandes; Sueli Mieko Oba-Shinjo; Janaina Macedo-da-Silva; Suely Kazue Nagahashi Marie; Giuseppe Palmisano
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 3.  LncRNA-miRNA-mRNA regulatory axes in endometrial cancer: a comprehensive overview.

Authors:  Abhishek Shetty; Thejaswini Venkatesh; Shama Prasada Kabbekodu; Rie Tsutsumi; Padmanaban S Suresh
Journal:  Arch Gynecol Obstet       Date:  2022-02-18       Impact factor: 2.493

4.  LINC00662 promotes cell viability and metastasis in esophageal squamous cell carcinoma by sponging miR-340-5p and upregulating HOXB2.

Authors:  Zhimei Zhang; Xuyang Liang; Ling Ren; Shuxian Zhang; Shouying Li; Tongxun Wan; Dazhou Xu; Shengxiang Lv
Journal:  Thorac Cancer       Date:  2020-07-07       Impact factor: 3.500

5.  Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.

Authors:  Mingdong Li; Shengrong Long; Jinqu Hu; Zan Wang; Chao Geng; Shaowu Ou
Journal:  Aging (Albany NY)       Date:  2019-11-06       Impact factor: 5.682

6.  LncRNA RGMB-AS1 Promotes Glioma Growth and Invasion Through miR-1200/HOXB2 Axis.

Authors:  Bailin Pan; Ming Zhao; Ning Wang; Longbiao Xu; Tianya Wu; Zequn Li
Journal:  Onco Targets Ther       Date:  2019-11-25       Impact factor: 4.147

7.  miR-4324 functions as a tumor suppressor in colorectal cancer by targeting HOXB2.

Authors:  Hailin Li; Guiling Zhu; Yanwei Xing; Yuekun Zhu; Daxun Piao
Journal:  J Int Med Res       Date:  2019-12-18       Impact factor: 1.671

8.  Long Noncoding RNA HOXB-AS1 Is Upregulated in Endometrial Carcinoma and Sponged miR-149-3p to Upregulate Wnt10b.

Authors:  Da Liu; Min Qiu; Lili Jiang; Kuiran Liu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

Review 9.  Emerging Role of Long Non-Coding RNAs in the Pathobiology of Glioblastoma.

Authors:  Omidvar Rezaei; Kasra Honarmand Tamizkar; Guive Sharifi; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Front Oncol       Date:  2021-02-03       Impact factor: 6.244

10.  Prediction of a competing endogenous RNA co-expression network as a prognostic marker in glioblastoma.

Authors:  Qunlong Peng; Runmin Li; Ying Li; Xiaoqian Xu; Wensi Ni; Huiran Lin; Liang Ning
Journal:  J Cell Mol Med       Date:  2020-10-13       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.